用户名: 密码: 验证码:
Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia
详细信息查看全文 | 推荐本文 |
摘要

Aim

The aim was to evaluate the therapeutic effectiveness of granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood mononuclear cells (PBMNCs) in critical limb ischemia (CLI) of type 2 diabetic patients.

Method

Forty diabetic patients with CLI were enrolled and randomized to treatment and control groups. In聽the treatment group, the patients received subcutaneous injections of recombinant human G-CSF (30聽MU/day) for 5 days to mobilize stem cells. PBMNCs were collected and transplanted by multiple intramuscular injections of 1 ml in 1-1.5-cm depth into ischemic limbs.

Results

At the end of 12 weeks of follow-up, the baseline and end point results in transplant group were as follows: Fontaine score improved from 3.8卤03 to 3卤0.5 (P=.0001), ankle brachial pressure index increased from 0.68卤0.24 to 0.87卤024 (P=.001), transcutaneous oxygen increased from 33卤14 mmHg to 44卤10 mmHg (P=.0001), and 6-min walking distance improved from 280卤82 m to 338卤98 m (P=.0001). Pain score decreased from 8.2卤1.3 to 5.63卤1.6 (P=.001), and the number of patients with limb ulcers was reduced from 9/20 (45%) to 3/20 (15%) (P=.031). In the control group, Fontaine score, 6-min walking distance, and pain score were improved; ankle brachial pressure index and transcutaneous oxygen pressure were not improved. The number of patients with limb ulcers did not change in the control group. There are improvement in amputation rates, collateral vessel development, and number of limb ulcers healed.

Conclusions

These results indicate that the autologous transplantation of G-CSF that mobilized PBMNCs in CLI diabetic patients is safe and effective in patient compliant reduction and improved perfusion.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700